- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Clopidogrel in 2020: A Reappraisal
Authors
Keywords
-
Journal
Cardiovascular Therapeutics
Volume 2020, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2020-03-28
DOI
10.1155/2020/8703627
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ‘Ten commandments’ for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization
- (2019) Franz-Josef Neumann et al. EUROPEAN HEART JOURNAL
- Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy After Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment
- (2019) Giuseppe Patti et al. AMERICAN JOURNAL OF CARDIOLOGY
- Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
- (2019) Dirk Sibbing et al. JACC-Cardiovascular Interventions
- A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
- (2019) Daniel M.F. Claassens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization
- (2018) Stefano Savonitto et al. CIRCULATION
- The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes
- (2018) Marco Ferlini et al. CORONARY ARTERY DISEASE
- Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018
- (2018) JM Boulanger et al. International Journal of Stroke
- Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes
- (2018) Francesca Maria Notarangelo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Sonia S Anand et al. LANCET
- Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
- (2018) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
- (2017) Thomas Cuisset et al. EUROPEAN HEART JOURNAL
- 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
- (2017) Victor Aboyans et al. EUROPEAN HEART JOURNAL
- Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
- (2017) Dirk Sibbing et al. LANCET
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
- (2017) William R. Hiatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT
- (2017) Paolo Zocca et al. EuroIntervention
- Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry
- (2017) Maximilian Tscharre et al. PLoS One
- Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations
- (2016) Leonardo De Luca et al. AMERICAN HEART JOURNAL
- Management of Critical Limb Ischemia
- (2016) Scott Kinlay Circulation-Cardiovascular Interventions
- The Role of Platelets in Cardiovascular Disease: Molecular Mechanisms
- (2016) Angeliki Papapanagiotou et al. CURRENT PHARMACEUTICAL DESIGN
- Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry
- (2016) Anders Sahlén et al. EUROPEAN HEART JOURNAL
- Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population
- (2016) De-Liang Shen et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
- (2016) Marc P. Bonaca et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- (2016) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Contemporary antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: 1-year outcomes from the GReek AntiPlatElet (GRAPE) Registry
- (2016) D. Alexopoulos et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial
- (2016) Guillaume Cayla et al. LANCET
- Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
- (2016) Peter M Rothwell et al. LANCET
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Nicholas J Kassebaum et al. LANCET
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
- (2016) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
- (2016) Kaare H. Bønaa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response
- (2016) Jean-Claude Bordet et al. THROMBOSIS AND HAEMOSTASIS
- Contemporary Use of Ticagrelor in Interventional Practice (from Blue Cross Blue Shield of Michigan Cardiovascular Consortium)
- (2015) Amrita M. Karve et al. AMERICAN JOURNAL OF CARDIOLOGY
- Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up
- (2015) Sami M.A. Alnasser et al. AMERICAN JOURNAL OF MEDICINE
- Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) TrialCLINICAL PERSPECTIVE
- (2015) Yilong Wang et al. CIRCULATION
- Building the Case for Clopidogrel as a World Health Organization Essential Medicine: Figure.
- (2015) Amisha Patel et al.
- Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
- (2015) Dániel Aradi et al. EUROPEAN HEART JOURNAL
- Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease
- (2015) Raffaele Piccolo et al. JACC-Cardiovascular Interventions
- Long-Term Safety of Drug-Eluting and Bare-Metal Stents
- (2015) Tullio Palmerini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention
- (2015) Philippe Généreux et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Switching P2Y12-receptor inhibitors in patients with coronary artery disease
- (2015) Fabiana Rollini et al. Nature Reviews Cardiology
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Building the Case for Clopidogrel as a World Health Organization Essential Medicine: Figure.
- (2015) Amisha Patel et al. Circulation-Cardiovascular Quality and Outcomes
- Rapid Evaluation after High-Risk TIA is Associated with Lower Stroke Risk
- (2014) Caren M. Wu et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States
- (2014) Jay P. Bae et al. CURRENT MEDICAL RESEARCH AND OPINION
- 2014 ESC/EACTS Guidelines on myocardial revascularization
- (2014) EUROPEAN HEART JOURNAL
- Novel antiplatelet agents in acute coronary syndrome
- (2014) Francesco Franchi et al. Nature Reviews Cardiology
- Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial
- (2014) Manesh R Patel et al. European Journal of Preventive Cardiology
- Treatment Patterns and Outcomes in Patients Undergoing Percutaneous Coronary Intervention Treated With Prasugrel or Clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR])
- (2013) Peter Damman et al. AMERICAN JOURNAL OF CARDIOLOGY
- Response Variability to P2Y12 Receptor Inhibitors
- (2013) Jolanta M. Siller-Matula et al. JACC-Cardiovascular Interventions
- Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding
- (2013) Udaya S. Tantry et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
- (2013) F Gerald R Fowkes et al. LANCET
- Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial
- (2013) Clemens von Birgelen et al. LANCET
- Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
- (2013) Yongjun Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Platelet Activation in Acute Coronary Syndromes
- (2012) Dimitrios A. Stakos et al. Current Vascular Pharmacology
- A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
- (2012) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients
- (2012) Clemens von Birgelen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
- (2012) Jean-Philippe Collet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)
- (2011) Giuseppe Patti et al. AMERICAN JOURNAL OF CARDIOLOGY
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clopidogrel–Drug Interactions
- (2011) Eric R. Bates et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genomics and Drug Response
- (2011) Liewei Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: Rationale and design of the Assessment with a double Randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and Clopidogrel after DES implantation, and (2) Treatment Interruption versus Continuation, 1 year after stenting (ARCTIC) study
- (2010) Jean-Philippe Collet et al. AMERICAN HEART JOURNAL
- Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
- (2010) Deepak L. Bhatt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Patients with peripheral arterial disease in the CHARISMA trial
- (2009) P. P. Cacoub et al. EUROPEAN HEART JOURNAL
- Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease
- (2009) Jeffrey S. Berger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search